These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23559196)

  • 1. West nile virus infection and myasthenia gravis.
    Leis AA; Szatmary G; Ross MA; Stokic DS
    Muscle Nerve; 2014 Jan; 49(1):26-9. PubMed ID: 23559196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. West Nile virus induces a post-infectious pro-inflammatory state that explains transformation of stable ocular myasthenia gravis to myasthenic crises.
    Hawkes MA; Hocker SE; Leis AA
    J Neurol Sci; 2018 Dec; 395():1-3. PubMed ID: 30267806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is West Nile Virus infection associated with myasthenia gravis?
    Altay FA; Güven H; Şentürk GÇ; Ferik S; Şencan İ; Çomoğlu S
    Trop Doct; 2017 Jan; 47(1):30-34. PubMed ID: 27342918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. West Nile Virus infection with hearing loss.
    McBride W; Gill KR; Wiviott L
    J Infect; 2006 Nov; 53(5):e203-5. PubMed ID: 16549202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seropositivity for West Nile Virus Antibodies in Patients Affected by Myasthenia Gravis.
    Greco M; Cofano P; Lobreglio G
    J Clin Med Res; 2016 Mar; 8(3):196-201. PubMed ID: 26858791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. West Nile virus and kidney disease.
    Barzon L; Pacenti M; Palù G
    Expert Rev Anti Infect Ther; 2013 May; 11(5):479-87. PubMed ID: 23627854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic options in autoimmune myasthenia gravis.
    García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
    Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immune globulin in myasthenia gravis.
    Gajdos P
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. West Nile virus infection in kidney and pancreas transplant recipients in the Dallas-Fort Worth Metroplex during the 2012 Texas epidemic.
    Yango AF; Fischbach BV; Levy M; Chandrakantan A; Tan V; Spak C; Melton L; Rice K; Barri Y; Rajagopal A; Klintmalm G
    Transplantation; 2014 May; 97(9):953-7. PubMed ID: 24827765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
    Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
    [No Abstract]   [Full Text] [Related]  

  • 11. West Nile virus neuroinvasive disease.
    Davis LE; DeBiasi R; Goade DE; Haaland KY; Harrington JA; Harnar JB; Pergam SA; King MK; DeMasters BK; Tyler KL
    Ann Neurol; 2006 Sep; 60(3):286-300. PubMed ID: 16983682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of myasthenia gravis.
    Saperstein DS; Barohn RJ
    Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis: clinical, immunological, and therapeutic advances.
    Romi F; Gilhus NE; Aarli JA
    Acta Neurol Scand; 2005 Feb; 111(2):134-41. PubMed ID: 15644074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically.
    Morelli MC; Sambri V; Grazi GL; Gaibani P; Pierro A; Cescon M; Ercolani G; Cavrini F; Rossini G; Capobianchi MR; Di Caro A; Menzo S; Pagliaro PP; Ghinelli F; Lazzarotto T; Landini MP; Pinna AD
    Clin Infect Dis; 2010 Aug; 51(4):e34-7. PubMed ID: 20597692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. West Nile virus encephalitis acquired via liver transplantation and clinical response to intravenous immunoglobulin: case report and review of the literature.
    Rhee C; Eaton EF; Concepcion W; Blackburn BG
    Transpl Infect Dis; 2011 Jun; 13(3):312-7. PubMed ID: 21235711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.
    Zisimopoulou P; Lagoumintzis G; Kostelidou K; Bitzopoulou K; Kordas G; Trakas N; Poulas K; Tzartos SJ
    J Neuroimmunol; 2008 Sep; 201-202():95-103. PubMed ID: 18667243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
    Saulat B; Maertens P; Hamilton WJ; Bassam BA
    Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
    [No Abstract]   [Full Text] [Related]  

  • 18. Excretion of West Nile virus in urine during acute infection.
    Barzon L; Pacenti M; Franchin E; Pagni S; Martello T; Cattai M; Cusinato R; Palù G
    J Infect Dis; 2013 Oct; 208(7):1086-92. PubMed ID: 23821721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.